Lars Fruergaard Jørgensen, the president and CEO of the Danish pharmaceutical company Novo Nordisk, has been named the Financial Times Person of the Year.
The publication praised him for his «unhurried, persistent but transformative innovation» that has made Novo Nordisk a global leader in diabetes care and a pioneer in other therapeutic areas.
«For his role in steering this remarkable company, the Financial Times has chosen Jørgensen as its Person of the Year,» the article said.
Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark. Its purpose is to drive change to defeat diabetes and other serious chronic diseases, such as obesity, rare blood and endocrine disorders.
